Navigation Links
New Clinical Trial Review: Leukemia Patients Treated by Bellicum Pharmaceuticals -- 91% remission, 94% Survival (median follow-up 301 Days) Source: Pluvia Research
Date:4/10/2017

April 10, 2017, a new clinical trial report released today compares the significance of historic results treating Acute Leukemia patients vs clinical trial data reported by Bellicum Pharmaceuticals (NASDAQ: BLCM). The clinical trial review was released by Pluvia Securities Research (PSR).

The report reviews data from 122 malignant and non-malignant patients treated with BPX-501 (Bellicum Pharmaceuticals, clinical trial identifier NCT01865617 & NCT02065869). Leukemia patients treated by Bellicum, (n=35) had an overall survival rate of 94% at 6 months compared to a historical 6 month leukemia survival rate of 78% (source: National Donor Marrow Program)

56 patients with non-malignant blood disorders are also treated in the Bellicum trial. These include patients with Sickle Cell disease, Thalassemia Major and Wiscott-Aldrich. The report issued by PSR compares historical survival of these diseases at 1yr (82-92%) with 100% survival of patients treated by Bellicum BPX-501.

The full PSR Clinical Trial Review of Bellicum BPX-501 is available for free download (here)

For Additional Information Contact:
Steve Pluvia
Pluvia Research
801.824.1549

Read the full story at http://www.prweb.com/releases/2017/04/prweb14229071.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. Allegheny Health Network Clinical Trial Examines Regorafenib as Maintenance Therapy for Colon Cancer
2. DrugDev Thought Leaders Share Experience and Insights on How Transformative Technology Improves Clinical Trials at Premier Pharma and Biotech Industry Conferences in Q2
3. Catalent Expands Kansas City Clinical Storage and Secondary Packaging Capabilities to Meet Growing Demand for Cold Chain Services
4. New DrugDev Educational Webinar Reveals How Biotechs and Smaller Pharmaceutical Companies Gain Site Attention and Engagement by Optimizing Clinical Trial Payments
5. FDAnews Announces — Medical Device Clinical Evaluation Reports: Complying with European Guidelines and the New MEDDEV 2.7/1 Rev. 4 Guidance Webinar, April 4, 2017
6. Catalent Wins Prestigious Clinical Supply Chain Excellence Award at BioPharma Asia Convention
7. Intrinsic Imaging Awarded Phase II Immuno-Oncology Clinical Trial for the Treatment of Non-Small Cell Lung Cancer and Small Cell Lung Cancer
8. Challenges and Innovation in Clinical Trial Supply to be Presented by Catalent Experts at Upcoming Conferences
9. Peanut Patch Continues to Show Promise in Extension of Latest Clinical Trial
10. New Clinical Data on Cryoablation For The Treatment Of Early Stage Breast Cancer To Be Presented At Susan G. Komen San Diego
11. ERT Clinical Trial Oversight Selected by Premier Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2019)... Mass. (PRWEB) , ... May 22, 2019 , ... ... of eClinical Solutions LLC is a finalist for the Entrepreneur Of ... the most prestigious business awards programs in the U.S., the program recognizes entrepreneurs ...
(Date:5/22/2019)... ... May 22, 2019 , ... Care to ... Health studying the economic impact of misdiagnosis of imaging procedures. According to Lisa ... the interpretations of the diagnostic imaging their employees were receiving, including CT scans ...
(Date:5/22/2019)... ST. LOUIS (PRWEB) , ... May 22, 2019 ... ... announced a new annual health observance, National Lifestyle Medicine Week, to take place ... employing each of the evidence-based therapeutic approaches of Lifestyle Medicine: a whole food, ...
(Date:5/22/2019)... OAKLAND, Calif. (PRWEB) , ... May 22, 2019 ... ... development academy for HR professionals, announced today the availability of Wellbeing at Work, ... aspects of corporate wellbeing. The program offers guidance and best-practice examples for ...
(Date:5/22/2019)... (PRWEB) , ... May 22, 2019 , ... ... Monday, May 20. The opening makes AdventHealth Ocala the only hospital in Marion ... now a pediatric inpatient unit for families in the area. The unit will ...
Breaking Medicine News(10 mins):
(Date:5/23/2019)... MATEO, Calif. (PRWEB) , ... May 23, 2019 , ... ... $250 Music and Arts Grant from California Casualty at http://www.calcasmusicartsgrant.com . The entry ... school administrators and instructors and hear over and over how their arts and performance ...
(Date:5/22/2019)... ... May 22, 2019 , ... Ziegler, a specialty ... the successful closing of the $22,375,000 Series 2019 for Trevecca Nazarene University. The ... of the Metropolitan Government of Nashville and Davidson County, Tennessee. Proceeds from the ...
(Date:5/22/2019)... (PRWEB) , ... May 22, 2019 , ... ... has released two new products, Ultra-Relief and Ultra-Relax, that are designed to increase ... products do not contain CBD, but instead contain terpenes and other natural ingredients ...
Breaking Medicine Technology: